AI-071 is under development for the treatment of coronavirus disease-2019 pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acute respiratory failure, immune-related ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Inspira Technologies Oxy BHN ( ($IINN) ) has issued an announcement. Inspira Technologies OXY B.H.N. Ltd. announced a collaboration with Zriha ...

The Extracorporeal Life Support Organization has documented the application of venovenous extracorporeal membrane oxygenation ...

Prophylactic respiratory support for patients after extubation is effective in improving their outcomes and prognosis.

The following is a summary of “Prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome,” published in the January ...

"While hMPV is not a new virus, and experts indicate the current outbreak is part of normal seasonal patterns, Inspira believes in being prepared," said Dagi Ben-Noon, CEO of Inspira. "Our increased ...

is being developed for the treatment of acute decompensated heart failure (ADHF) and cardiogenic shock; Aerosurf, a lucinactant for inhalation, and lyophilized KL4 surfactant intratracheal suspension, ...

The mystery disease affecting people in the Democratic Republic of the Congo most likely is caused by a respiratory virus ... with increasing levels of acute malnutrition.” ...